The Pay of Cytomedix’s Top Executives
Cytomedix, Inc. (OTC:CMXI), a Gaithersburg, Md. based biotechnology company, disclosed the compensation of its top executives in a recent regulatory filing.
Cytomedix, Inc. develops adult stem cell products that enhance the body's natural healing processes, particularly for wound and tissue repair.
The company reported net income for 2011 of $0.81 million or $0.02 per basic share compared with a net loss of $2.17 million or $0.05 per share.
Citybizlist Partner News
- Rosenberg Martin Greenberg, LLP - Should Technology Reinvent the Classroom?
- Merritt Properties - Greater Baltimore Board of Realtors Signs Lease for Office Space at Merritt’s Timonium Center
- MacKenzie - MacKenzie Commercial Real Estate Recap - April 27th - May 10th, 2013
- St. John Properties - Bill Holzman Promoted to VP, Retail Leasing for St. John Properties